POERIO, NOEMI
 Distribuzione geografica
Continente #
NA - Nord America 3.147
AS - Asia 1.374
EU - Europa 1.129
SA - Sud America 181
Continente sconosciuto - Info sul continente non disponibili 178
AF - Africa 96
OC - Oceania 30
Totale 6.135
Nazione #
US - Stati Uniti d'America 3.049
IT - Italia 440
SG - Singapore 423
CN - Cina 185
SA - Arabia Saudita 142
BR - Brasile 133
RU - Federazione Russa 124
DE - Germania 122
GB - Regno Unito 110
HK - Hong Kong 82
JP - Giappone 77
VN - Vietnam 75
IE - Irlanda 66
BD - Bangladesh 64
CA - Canada 60
IN - India 59
IR - Iran 42
FR - Francia 41
PK - Pakistan 38
KR - Corea 36
NL - Olanda 32
JO - Giordania 28
SE - Svezia 26
AU - Australia 25
FI - Finlandia 24
PH - Filippine 24
ES - Italia 21
UA - Ucraina 21
EG - Egitto 19
ID - Indonesia 17
MX - Messico 17
PL - Polonia 17
ZA - Sudafrica 17
ET - Etiopia 16
NG - Nigeria 16
TR - Turchia 15
AT - Austria 14
IL - Israele 12
CH - Svizzera 11
AR - Argentina 10
BE - Belgio 10
CO - Colombia 9
CZ - Repubblica Ceca 9
IQ - Iraq 9
TW - Taiwan 9
EC - Ecuador 8
MY - Malesia 8
CL - Cile 7
GH - Ghana 6
NO - Norvegia 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
EE - Estonia 5
GT - Guatemala 5
NZ - Nuova Zelanda 5
PE - Perù 5
TH - Thailandia 5
VE - Venezuela 5
ER - Eritrea 4
GR - Grecia 4
JM - Giamaica 4
NP - Nepal 4
RS - Serbia 4
SC - Seychelles 4
UZ - Uzbekistan 4
CR - Costa Rica 3
HN - Honduras 3
KE - Kenya 3
KG - Kirghizistan 3
LT - Lituania 3
NI - Nicaragua 3
PY - Paraguay 3
QA - Qatar 3
BG - Bulgaria 2
DK - Danimarca 2
DZ - Algeria 2
HU - Ungheria 2
LY - Libia 2
MA - Marocco 2
PS - Palestinian Territory 2
RO - Romania 2
SI - Slovenia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CG - Congo 1
EU - Europa 1
GA - Gabon 1
IS - Islanda 1
LU - Lussemburgo 1
OM - Oman 1
PA - Panama 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 5.960
Città #
Wilmington 406
Houston 398
Ashburn 275
Singapore 248
San Jose 221
Chandler 148
Jeddah 131
Council Bluffs 118
Rome 115
Fairfield 82
Beijing 78
New York 78
Hong Kong 60
Los Angeles 53
Dublin 50
Tokyo 50
Milan 44
Ann Arbor 42
Seattle 42
Santa Clara 41
Hamburg 40
Woodbridge 39
Medford 38
The Dalles 37
Amman 28
Philadelphia 28
Hanoi 27
Cambridge 23
Munich 23
Seoul 23
Ho Chi Minh City 22
São Paulo 22
Montreal 19
North Bergen 19
Lawrence 17
Buffalo 16
Dallas 16
Denver 16
Cairo 15
Lauterbourg 15
Naples 15
Atlanta 14
Helsinki 14
Menlo Park 14
Minneapolis 14
Moscow 14
San Diego 14
Chicago 13
Frankfurt am Main 13
Toronto 13
Mumbai 12
Nuremberg 12
Warsaw 12
Chennai 11
Phoenix 11
Birmingham 10
Brooklyn 10
Florence 10
London 10
Madrid 10
Orem 10
Southampton 10
Central 9
Jakarta 9
Johannesburg 9
Las Vegas 9
Turin 9
Amsterdam 8
Lappeenranta 8
Oceanside 8
Quezon City 8
San Juan 8
Vienna 8
Boardman 7
Islamabad 7
Kochi 7
Melbourne 7
Mexico City 7
Woodland 7
Bologna 6
Brisbane 6
Engelhard 6
Manchester 6
Medellín 6
Osimo 6
Palermo 6
Peshawar 6
Redwood City 6
Stockholm 6
Tehran 6
Thetford Center 6
Accra 5
Des Moines 5
Faisalabad 5
Gothenburg 5
Guatemala City 5
Jacksonville 5
Lahore 5
Norwalk 5
Padova 5
Totale 3.681
Nome #
Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307 686
Exploiting phages–bacteria co-evolution to overcome phage resistance and to ease the selection of new phage particles 605
Liposomes loaded with bioactive lipids enhance antibacterial innate immunity irrespective of drug resistance 380
Adipocyte metabolism is improved by TNF receptor-targeting small RNAs identified from dried nuts 347
Hydroalcoholic extract from Origanum vulgare induces a combined anti-mycobacterial and anti-inflammatory response in innate immune cells 263
Preclinical study of a combined host- and pathogen directed approach based on bioactive liposomes and bacteriophages against Mycobacterium abscessus infection 254
First Case of Patient With Two Homozygous Mutations in MYD88 and CARD9 Genes Presenting With Pyogenic Bacterial Infections, Elevated IgE, and Persistent EBV Viremia 252
The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases 231
Characterization of vb_stus_mmda13, a newly discovered bacteriophage infecting the agar-degrading species sphingomonas turrisvirgatae 213
Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy 209
Redox activation of ATM enhances GSNOR translation to sustain mitophagy and tolerance to oxidative stress 194
Fighting MDR-Klebsiella pneumoniae infections by a combined host- and pathogen-directed therapeutic approach 158
Combined host- and pathogen-directed therapy for the control of mycobacterium abscessus infection 158
Phage-resistance in Klebsiella pneumoniae clinical isolates may correlate to augmented clearance by phagocytes 156
Phage-resistance mechanism in KPC-producing Klebsiella pneumoniae of the clonal group 258 clade II lineage 148
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 147
Liposomes Loaded With Phosphatidylinositol 5-Phosphate Improve the Antimicrobial Response to Pseudomonas aeruginosa in Impaired Macrophages From Cystic Fibrosis Patients and Limit Airway Inflammatory Response 137
Phage Resistance Is Associated with Decreased Virulence in KPC-Producing Klebsiella pneumoniae of the Clonal Group 258 Clade II Lineage 135
CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance and immune homeostasis 134
Phosphatidylserine liposomes reduce inflammatory response, mycobacterial viability and HIV replication in coinfected human macrophages 131
Mucoadhesive Rifampicin-Liposomes for the Treatment of Pulmonary Infection by Mycobacterium abscessus: Chitosan or ε-Poly-L-Lysine Decoration 127
Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages 127
Bioactive liposomes for the control of Mycobacterium abscessus infection. 124
Immunization with mycobacterium tuberculosisantigens encapsulated in phosphatidylserine liposomes improves protection afforded by BCG 116
Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307 115
Phosphaditylserine liposomes as a possible candidate for the therapeutic management of Mycobacterium abscessus infection in CF patients 106
Phosphatidylserine liposomes induce a phagosome acidification-dependent and ROS-mediated intracellular killing of Mycobacterium abscessus in human macrophages 93
Evaluation of phages and liposomes as combination therapy to counteract Pseudomonas aeruginosa infection in wild-type and CFTR-null models 91
Phosphatidylinositol 5-Phosphate-Loaded Apoptotic Body-Like Liposomes for Mycobacterium abscessus Infection Management in Patients With Cystic Fibrosis 84
vB_KpM_GP-7: a novel myovirus targeting capsule-deficient, phage-resistant Klebsiella pneumoniae 41
Production and characterization of a phage-encoded capsular polysaccharide endoglycosidase targeting Sequence Type 307 Klebsiella pneumoniae strains 39
Phosphatidylserine liposomes for Mycobacterium abscessus infections management in people with cystic fibrosis non-eligible for CFTR modulators 37
Lytic bacteriophages against Klebsiella pneumoniae and their impact on bacterial virulence 36
Phosphatidylinositol 5-phosphate-loaded-apoptotic body-like liposomes for Mycobacterium abscessus infections management in people with cystic fibrosis 31
Enhanced clearance of phage-resistant Klebsiella pneumoniae strains by the innate immune system 30
Totale 6.135
Categoria #
all - tutte 20.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.793


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022226 0 0 0 1 3 5 12 71 24 13 16 81
2022/2023319 22 39 11 41 43 59 24 19 36 0 16 9
2023/2024996 27 4 7 145 114 244 139 95 62 43 55 61
2024/20251.041 82 125 113 79 58 90 96 59 98 73 79 89
2025/20261.704 125 72 144 153 167 79 242 147 145 188 182 60
2026/2027689 70 77 294 248 0 0 0 0 0 0 0 0
Totale 6.135